title: No effect of spironolactone on bulimia nervosa symptoms.
authors.forename: Jörn
authors.initials: J
authors.lastname: von Wietersheim
authors.forename: Vera
authors.initials: V
authors.lastname: Müler-Bock
authors.forename: Stephan
authors.initials: S
authors.lastname: Rauh
authors.forename: Bettina
authors.initials: B
authors.lastname: Danner
authors.forename: Karin
authors.initials: K
authors.lastname: Chrenko
authors.forename: Georg
authors.initials: G
authors.lastname: Bühler
mesh_terms: D000328:Adult; D052018:Bulimia Nervosa / Q000188:drug therapy* / Q000473:pathology; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D008901:Mineralocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids; D013148:Spironolactone